argenx SE ADR's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters.
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Product net sales | $4.2B | $2.2B | $1.2B | $400.7M |
| Other operating income | $96.7M | $61.8M | $42.3M | $34.5M |
| Total operating income | $4.2B | $2.3B | $1.3B | $445.3M |
| Cost of sales | ($450.7M) | ($227.3M) | ($117.8M) | ($29.4M) |
| Research and development expenses | ($1.4B) | ($983.4M) | ($859.5M) | ($663.4M) |
| Selling, general and administrative expenses | ($1.4B) | ($1.1B) | ($711.9M) | ($472.1M) |
| Loss from investment in a joint venture | ($12.4M) | ($7.6M) | ($4.4M) | ($677.0K) |
| Total operating expenses | ($3.2B) | ($2.3B) | ($1.7B) | ($1.2B) |
| Operating profit/(loss) | $1.1B | ($21.7M) | ($425.0M) | ($720.3M) |
| Financial income | $163.1M | $157.5M | $107.4M | $27.7M |
| Financial expense | ($4.1M) | ($2.5M) | ($906.0K) | ($3.9M) |
| Exchange gains/(losses) | $65.8M | ($48.2M) | $14.1M | ($32.7M) |
| Profit/(Loss) for the year before taxes | $1.3B | $85.2M | ($304.5M) | ($729.3M) |
| Income tax benefit | $13.4M | $747.9M | $9.4M | $19.7M |
| Profit/(Loss) for the year | $1.3B | $833.0M | ($295.1M) | ($709.6M) |
| Owners of the parent | $1.3B | $833.0M | ($295.1M) | ($709.6M) |
| Weighted average number of shares used for basic profit/(loss) per share (in shares) | $61295149.00 | $59855585.00 | $57169253.00 | $54381371.00 |
| Basic profit/(loss) per share (in USD per share) | $21.08 | $13.92 | -$5.16 | -$13.05 |
| Weighted average number of shares used for diluted profit/(loss) per share (in shares) | $66029215.00 | $65177815.00 | — | — |
| Diluted profit/(loss) per share (in USD per share) | $19.57 | $12.78 | -$5.16 | -$13.05 |
| Line item | Jun 30, 2026 · YTD | Jun 30, 2025 · YTD | Jun 30, 2024 · YTD | Jun 30, 2023 · YTD |
|---|---|---|---|---|
| Product net sales | $2.8B | $1.7B | $875.9M | $487.3M |
| Other operating income | $41.0M | $35.9M | $23.3M | $21.2M |
| Total operating income | $2.9B | $1.8B | $901.9M | $510.9M |
| Cost of sales | ($266.0M) | ($191.6M) | ($95.6M) | ($42.4M) |
| Research and development expenses | ($929.0M) | ($636.8M) | ($450.3M) | ($361.4M) |
| Selling, general and administrative expenses | ($772.0M) | ($601.1M) | ($491.7M) | ($311.1M) |
| Total operating expenses | ($2.0B) | ($1.4B) | ($1.0B) | ($716.8M) |
| Operating profit | $887.0M | $340.0M | ($138.9M) | ($205.8M) |
| Financial income | $92.0M | $75.5M | $77.8M | $37.0M |
| Financial expense | ($2.0M) | ($2.3M) | ($1.1M) | ($395.0K) |
| Exchange (losses)/gains | ($19.0M) | $76.0M | ($27.2M) | $9.2M |
| Profit for the period before taxes | $958.0M | $489.3M | ($89.4M) | ($160.0M) |
| Income tax expense | ($119.0M) | ($74.4M) | $56.8M | $36.8M |
| Profit for the period | $838.0M | $414.8M | ($32.5M) | ($123.2M) |
| Owners of the parent | $838.0M | $414.8M | ($32.5M) | ($123.2M) |
| Weighted average number of shares used for basic profit per share (in shares) | $62185445.00 | $61034202.00 | $59400217.00 | $55690873.00 |
| Basic profit per share (in USD per share) | $13.47 | $6.80 | -$0.55 | -$2.21 |
| Weighted average number of shares used for diluted profit per share (in shares) | $64409488.00 | $65653007.00 | — | — |
| Diluted profit per share (in USD per share) | $13.00 | $6.32 | -$0.55 | -$2.21 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Property, plant and equipment | $48.2M | $43.5M | $22.7M | $16.2M |
| Intangible assets | $272.1M | $181.4M | $125.2M | $174.9M |
| Deferred tax assets | $1.3B | $924.3M | $97.2M | $79.2M |
| Research and development incentive receivables | $86.2M | $94.9M | $76.7M | $47.5M |
| Investment in a joint venture | $3.4M | $9.3M | $9.9M | $1.3M |
| Prepaid expenses | $25.8M | $23.6M | $47.3M | — |
| Other non-current assets | $52.0M | $42.4M | $39.7M | $40.9M |
| Total non‑current assets | $1.8B | $1.3B | $418.7M | $360.1M |
| Inventories | $473.5M | $407.2M | $310.6M | $228.4M |
| Prepaid expenses | $328.5M | $187.9M | $134.1M | $76.0M |
| Trade and other receivables | $1.6B | $904.5M | $496.7M | $275.7M |
| Research and development incentive receivables | $10.4M | $4.6M | $2.6M | $1.6M |
| Financial assets | $948.8M | $1.9B | $1.1B | $1.4B |
| Cash and cash equivalents | $3.5B | $1.5B | $2.0B | $800.7M |
| Total current assets | $6.9B | $4.9B | $4.1B | $2.8B |
| Total assets | $8.7B | $6.2B | $4.5B | $3.1B |
| Share capital | $7.4M | $7.2M | $7.1M | $6.6M |
| Share premium | $6.2B | $5.9B | $5.7B | $4.3B |
| Translation differences | $138.6M | $126.8M | $131.5M | $129.3M |
| Accumulated losses | ($279.8M) | ($1.6B) | ($2.4B) | ($2.1B) |
| Other reserves | $1.3B | $987.1M | $712.3M | $477.7M |
| Total equity | $7.3B | $5.5B | $4.1B | $2.8B |
| Provisions for employee benefits | $3.1M | $1.8M | $1.4M | $870.0K |
| Lease liabilities | $36.3M | $32.5M | $15.4M | $9.0M |
| Deferred tax liabilities | $0 | $0 | $5.2M | $8.4M |
| Total non-current liabilities | $39.4M | $34.3M | $22.0M | $18.3M |
| Lease liabilities | $10.8M | $6.5M | $4.6M | $3.4M |
| Trade and other payables | $1.3B | $650.0M | $414.0M | $295.7M |
| Tax liabilities | $42.2M | $13.4M | $4.3M | $3.2M |
| Total current liabilities | $1.3B | $669.9M | $423.0M | $302.3M |
| Total liabilities | $1.4B | $704.2M | $445.0M | $320.6M |
| Total equity and liabilities | $8.7B | $6.2B | $4.5B | $3.1B |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 |
|---|---|---|---|---|
| Property, plant and equipment | $52.0M | $45.8M | $36.9M | $14.7M |
| Intangible assets | $266.0M | $219.0M | $141.8M | $189.9M |
| Deferred tax assets | $1.4B | $899.6M | $174.6M | $138.8M |
| Research and development incentive receivables | $69.0M | $100.5M | $91.2M | $60.0M |
| Prepaid expenses | $24.0M | $23.6M | $47.3M | $47.3M |
| Other non-current assets | $124.0M | $46.7M | $34.3M | $39.2M |
| Total non‑current assets | $2.0B | $1.3B | $532.8M | $502.3M |
| Inventories | $371.0M | $340.6M | $326.5M | $201.1M |
| Prepaid expenses | $572.0M | $362.7M | $179.4M | $138.8M |
| Trade and other receivables | $1.9B | $1.2B | $652.9M | $353.2M |
| Research and development incentive receivables | $10.0M | $1.2M | $2.7M | $1.4M |
| Financial assets | $1.6B | $1.8B | $1.7B | $886.4M |
| Cash and cash equivalents | $3.6B | $2.1B | $1.4B | $1.1B |
| Total current assets | $8.1B | $5.8B | $4.3B | $2.7B |
| Total assets | $10.0B | $7.2B | $4.8B | $3.2B |
| Share capital | $7.0M | $7.3M | $7.1M | $6.7M |
| Share premium | $6.3B | $6.0B | $5.7B | $4.4B |
| Translation differences | $138.0M | $133.3M | $128.9M | $130.0M |
| Retained earnings/(accumulated losses) | $558.0M | ($1.2B) | ($2.4B) | ($2.2B) |
| Other reserves | $1.4B | $1.1B | $816.1M | $580.0M |
| Total equity | $8.4B | $6.1B | $4.3B | $2.9B |
| Provisions for employee benefits | $4.0M | $2.4M | $1.6M | $1.0M |
| Lease liabilities | $36.0M | $35.6M | $28.1M | $8.0M |
| Total non-current liabilities | $40.0M | $37.9M | $34.7M | $17.9M |
| Lease liabilities | $11.0M | $7.6M | $5.9M | $3.2M |
| Trade and other payables | $1.5B | $1.0B | $479.8M | $310.0M |
| Tax liabilities | $49.0M | $18.2M | $13.9M | $4.6M |
| Total current liabilities | $1.6B | $1.0B | $499.6M | $317.8M |
| Total liabilities | $1.6B | $1.1B | $534.3M | $335.7M |
| Total equity and liabilities | $10.0B | $7.2B | $4.8B | $3.2B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Operating profit/(loss) | $1.1B | ($21.7M) | ($425.0M) | ($720.3M) |
| Amortization of intangible assets | $14.9M | $10.3M | $105.7M | $99.8M |
| Depreciation of property, plant and equipment | $13.2M | $7.2M | $5.6M | $4.6M |
| Provisions for employee benefits | $1.2M | $432.0K | $573.0K | $459.0K |
| Expense recognized in respect of share-based payments | $248.1M | $235.2M | $233.0M | $157.0M |
| Fair value gains on financial assets at fair value through profit or loss | ($11.6M) | ($3.8M) | — | ($4.3M) |
| Loss from investment in a joint venture | $12.4M | $7.6M | $4.4M | $677.0K |
| Other non-cash expenses/(benefit) | $31.6M | ($277.0K) | $2.1M | — |
| Adjustments for non-cash items | $1.4B | $235.0M | ($73.7M) | ($462.1M) |
| (Increase)/decrease in trade and other receivables | ($802.3M) | ($423.1M) | ($185.7M) | ($222.3M) |
| (Increase)/decrease in inventories | ($99.0M) | ($96.0M) | ($83.0M) | ($119.3M) |
| (Increase)/decrease in current prepaid expenses | ($140.0M) | — | — | — |
| (Increase)/decrease in other current assets | ($5.7M) | ($56.2M) | ($59.0M) | ($18.3M) |
| Increase/(decrease) in trade and other payables | $612.3M | $246.3M | $95.6M | $329.0K |
| (Increase)/decrease in other non‑current assets | $14.2M | ($19.9M) | ($29.4M) | ($16.2M) |
| (Increase)/decrease in non-current prepaid expense | ($2.2M) | $23.7M | ($47.3M) | — |
| Net cash flows from/(used) in operating activities, before interest and taxes | $940.9M | ($90.2M) | ($382.6M) | ($837.8M) |
| Interest paid | ($900.0K) | ($392.0K) | ($211.0K) | ($851.0K) |
| Income taxes (paid)/received | ($254.9M) | $7.8M | ($37.5M) | ($24.1M) |
| Net cash flows from/(used) in operating activities | $685.2M | ($82.7M) | ($420.3M) | ($862.8M) |
| Purchase of intangible assets | ($105.5M) | ($66.5M) | ($43.0M) | ($103.0M) |
| Purchase of property, plant and equipment | ($6.2M) | ($1.8M) | ($812.0K) | ($837.0K) |
| Purchase of current financial assets | ($1.4B) | ($2.2B) | ($1.3B) | ($1.7B) |
| Sale of current financial assets | $2.4B | $1.4B | $1.5B | $1.3B |
| Interest received | $162.7M | $111.6M | $92.8M | $13.1M |
| Investment in a joint venture | ($6.5M) | ($7.0M) | ($13.0M) | ($2.0M) |
| Net cash flows from/(used in) investing activities | $984.0M | ($717.6M) | $308.2M | ($461.2M) |
| Principal elements of lease payments | ($4.1M) | ($7.6M) | ($3.8M) | ($4.2M) |
| Proceeds from issue of new shares, gross amount | 0 | 0 | 1.2B | 761.0M |
| Issue costs paid | $0 | $0 | ($821.0K) | ($781.0K) |
| Exchange (losses)/gains from currency conversion on proceeds from issue of new shares | 0 | 0 | -1.5M | 410.0K |
| Payment of employee withholding taxes relating to restricted stock unit awards | ($41.3M) | ($21.9M) | ($12.1M) | ($5.9M) |
| Proceeds from exercise of stock options | $278.4M | $309.3M | $158.3M | $93.2M |
| Net cash flows from financing activities | $233.0M | $279.8M | $1.3B | $843.8M |
| Increase/(decrease) in cash and cash equivalents | $1.9B | ($520.6M) | $1.2B | ($480.2M) |
| Cash and cash equivalents at the beginning of the year | $1.5B | $2.0B | $800.7M | $1.3B |
| Exchange gains/(losses) on cash and cash equivalents | $89.1M | ($28.3M) | $23.5M | ($53.7M) |
| Cash and cash equivalents at the end of the year | $3.5B | $1.5B | — | — |
| Line item | Jun 30, 2026 · YTD | Jun 30, 2025 · YTD | Jun 30, 2024 · YTD | Jun 30, 2023 · YTD |
|---|---|---|---|---|
| Operating profit | $887.0M | $340.0M | ($138.9M) | ($205.8M) |
| Amortization of intangible assets | $9.0M | $6.3M | $5.0M | $43.0K |
| Depreciation of property, plant and equipment | $8.0M | $7.0M | $3.7M | $2.7M |
| Provisions for employee benefits | $1.0M | $480.0K | $143.0K | $138.0K |
| Expense recognized in respect of share-based payments | $117.0M | $110.8M | $102.4M | $102.1M |
| Fair value gains on financial assets at fair value through profit or loss | $4.0M | $0 | ($445.0K) | — |
| Other non-cash expenses/(benefit) | $48.0M | $30.6M | $8.0K | — |
| Adjustments for non-cash items | $1.1B | $500.2M | ($24.9M) | ($99.0M) |
| (Increase)/decrease in trade and other receivables | ($377.0M) | ($359.6M) | ($97.6M) | ($68.1M) |
| (Increase)/decrease in inventories | $60.0M | $35.0M | ($16.1M) | $27.2M |
| (Increase)/decrease in current prepaid expenses | ($244.0M) | — | — | — |
| (Increase)/decrease in other current assets | $1.0M | ($170.2M) | ($45.8M) | ($62.5M) |
| Increase/(decrease) in trade and other payables | $251.0M | $359.5M | $76.7M | ($616.0K) |
| (Increase)/decrease in other non‑current assets | $11.0M | $7.1M | ($18.1M) | ($11.6M) |
| (Increase)/decrease in non-current prepaid expense | $2.0M | — | — | — |
| Net cash flows from operating activities, before interest and taxes | $778.0M | $372.0M | ($125.8M) | ($261.9M) |
| Interest paid | $0 | ($664.0K) | ($157.0K) | ($78.0K) |
| Income taxes paid | ($127.0M) | ($9.5M) | $1.3M | ($23.5M) |
| Net cash flows from operating activities | $651.0M | $361.8M | ($124.7M) | ($285.4M) |
| Purchase of intangible assets | ($5.0M) | ($43.8M) | ($21.5M) | — |
| Purchase of property, plant and equipment | ($3.0M) | ($5.2M) | ($811.0K) | ($479.0K) |
| Purchase of other non-current assets | ($84.0M) | — | — | — |
| Purchase of current financial assets | ($1.6B) | ($1.1B) | ($1.1B) | ($267.2M) |
| Sale of current financial assets | $988.0M | $1.2B | $568.4M | $780.3M |
| Interest received | $100.0M | $72.5M | $48.6M | $27.4M |
| Investment in a joint venture | ($4.0M) | ($6.5M) | — | ($13.0M) |
| Net cash flows (used in)/from investing activities | ($658.0M) | $62.3M | ($513.8M) | $527.0M |
| Principal elements of lease payments | ($7.0M) | ($1.0M) | ($3.6M) | ($2.2M) |
| Payment of employee withholding taxes relating to restricted stock unit awards | ($8.0M) | ($4.5M) | ($1.8M) | ($604.0K) |
| Proceeds from exercise of stock options | $119.0M | $79.0M | $45.5M | $65.1M |
| Net cash flows from financing activities | $104.0M | $73.5M | $40.1M | $62.3M |
| Increase in cash and cash equivalents | $97.0M | — | — | — |
| Cash and cash equivalents at the beginning of the period | $3.5B | $1.5B | $2.0B | $800.7M |
| Exchange (losses)/gains on cash and cash equivalents | ($4.0M) | $88.4M | ($12.3M) | $6.0M |
| Cash and cash equivalents at the end of the period | $3.6B | $2.1B | $1.4B | $1.1B |
argenx SE ADR score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.